Stefan Verlohren

Sitert av

	Alle	Siden 2020
Sitater	9862	4806
h-indeks	45	33
i10-indeks	74	67

1100

550

275

825

20052006200720082009201020112012201320142015201620172018201920202021202220232024202529 26 60 48 73 153 131 255 315 388 419 638 672 913 775 778 895 928 990 1047 153

Offentlig tilgang

Vis alle

28 artikler

2 artikler

tilgjengelige

ikke tilgjengelige

Basert på finansieringsmandater

Medforfattere

Prof. Dr. Wolfgang HenrichCharite - BerlinVerifisert e-postadresse på med.wayne.edu
Ignacio Herraizprofesor de Obstetricia y Ginecología, Universidad Complutense de MadridVerifisert e-postadresse på ucm.es
Joachim DudenhausenCharité University Medicine BerlinVerifisert e-postadresse på charite.de
Sarosh RanaUniversity of ChicagoVerifisert e-postadresse på bsd.uchicago.edu
Manu VatishUniversity of OxfordVerifisert e-postadresse på wrh.ox.ac.uk
S. Ananth KarumanchiCedars-Sinai Medical Center; Beth Israel Deaconess Medical Center, Harvard Medical SchoolVerifisert e-postadresse på csmc.edu
sas SalahuddinInstructor, Harvard Medical SchoolVerifisert e-postadresse på bidmc.harvard.edu
Maik GollaschProfessor of Medicine, University Medicine Greifswald & Charité/MDC BerlinVerifisert e-postadresse på charite.de
Berthold HuppertzMedizinische Universität GrazVerifisert e-postadresse på medunigraz.at
Pavel CaldaProfessor, First Faculty of Medicine, Charles University and General University Hospital in PragueVerifisert e-postadresse på gynstart.cz
Basky ThilaganathanProfessor of Fetal MedicineVerifisert e-postadresse på pobox.com
Andreas BusjahnHealthTwiSt GmbHVerifisert e-postadresse på healthtwist.de
Camille E. Powe M.D.Massachusetts General HospitalVerifisert e-postadresse på mgh.harvard.edu
Liona C. PoonThe Chinese University of Hong Kong; King's College LondonVerifisert e-postadresse på cuhk.edu.hk
Andrei TintuVerifisert e-postadresse på erasmusmc.nl
Sofia CerdeiraUniversity of OxfordVerifisert e-postadresse på wrh.ox.ac.uk
Asma KhalilSt George's University of LondonVerifisert e-postadresse på sgul.ac.uk
Fatima CrispiConsultant in MaternalFetal Medicine at BCNatal, Associate Professor at University of BarcelonaVerifisert e-postadresse på clinic.cat
Yu HuangDepartment of Biomedical Sciences, City University of Hong Kong, Hong KongVerifisert e-postadresse på cityu.edu.hk
Michele HackerBeth Israel Deaconess Medical Center, Harvard Medical SchoolVerifisert e-postadresse på hsph.harvard.edu

Følg

Stefan Verlohren

Professor of Obstetrics, Department of Obstetrics, Charité - Universitätsmedizin Berlin

Verifisert e-postadresse på charite.de - Startside

Preeclampsia - sFlt-1 - PlGF - pregnancy - hypertension


Tittel Sorter etter sitater Sorter etter år Sorter etter tittel	Sitert av Sitert av	År
Predictive value of the sFlt-1: PlGF ratio in women with suspected preeclampsia H Zeisler, E Llurba, F Chantraine, M Vatish, AC Staff, M Sennström, ... New England Journal of Medicine 374 (1), 13-22, 2016	1831	2016
Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia S Rana, CE Powe, S Salahuddin, S Verlohren, FH Perschel, RJ Levine, ... Circulation 125 (7), 911-919, 2012	813	2012
An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia S Verlohren, A Galindo, D Schlembach, H Zeisler, I Herraiz, MG Moertl, ... American journal of obstetrics and gynecology 202 (2), 161. e1-161. e11, 2010	659	2010
The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients S Verlohren, I Herraiz, O Lapaire, D Schlembach, M Moertl, H Zeisler, ... American journal of obstetrics and gynecology 206 (1), 58. e1-58. e8, 2012	621	2012
New gestational phase–specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia S Verlohren, I Herraiz, O Lapaire, D Schlembach, H Zeisler, P Calda, ... Hypertension 63 (2), 346-352, 2014	475	2014
Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries S Verlohren, G Dubrovska, SY Tsang, K Essin, FC Luft, Y Huang, ... Hypertension 44 (3), 271-276, 2004	344	2004
Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice H Stepan, I Herraiz, D Schlembach, S Verlohren, S Brennecke, ... Ultrasound in Obstetrics & Gynecology 45 (3), 241, 2015	341	2015
Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia S Verlohren, H Stepan, R Dechend Clinical science 122 (2), 43-52, 2012	228	2012
Clinical characterization and outcomes of preeclampsia with normal angiogenic profile S Rana, WT Schnettler, C Powe, J Wenger, S Salahuddin, AS Cerdeira, ... Hypertension in pregnancy 32 (2), 189-201, 2013	203	2013
Mechanisms of ADRF release from rat aortic adventitial adipose tissue G Dubrovska, S Verlohren, FC Luft, M Gollasch American Journal of Physiology-Heart and Circulatory Physiology 286 (3 …, 2004	192	2004
Hypoxia induces dilated cardiomyopathy in the chick embryo: mechanism, intervention, and long-term consequences A Tintu, E Rouwet, S Verlohren, J Brinkmann, S Ahmad, F Crispi, ... PloS one 4 (4), e5155, 2009	170	2009
Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia S Verlohren, SP Brennecke, A Galindo, SA Karumanchi, LB Mirkovic, ... Pregnancy hypertension 27, 42-50, 2022	143	2022
Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age–matched case study F Herse, S Verlohren, K Wenzel, J Pape, DN Muller, S Modrow, ... Hypertension 53 (2), 393-398, 2009	142	2009
Uterine artery Doppler, birth weight and timing of onset of pre‐eclampsia: providing insights into the dual etiology of late‐onset pre‐eclampsia S Verlohren, K Melchiorre, A Khalil, B Thilaganathan Ultrasound in Obstetrics & Gynecology 44 (3), 293-298, 2014	140	2014
Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)/PlGF (placental growth factor)-ratio in the clinical routine: a real … LA Dröge, FH Perschel, N Stütz, A Gafron, L Frank, A Busjahn, W Henrich, ... Hypertension 77 (2), 461-471, 2021	136	2021
Soluble fms‐like tyrosine kinase‐1 to placental growth factor ratio: ruling out pre‐eclampsia for up to 4 weeks and value of retesting H Zeisler, E Llurba, FJ Chantraine, M Vatish, AC Staff, M Sennström, ... Ultrasound in Obstetrics & Gynecology 53 (3), 367-375, 2019	136	2019
Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia S Rana, MR Hacker, AM Modest, S Salahuddin, KH Lim, S Verlohren, ... Hypertension 60 (2), 451-458, 2012	134	2012
Update on the diagnosis and prognosis of preeclampsia with the aid of the sFlt-1/PlGF ratio in singleton pregnancies I Herraiz, E Llurba, S Verlohren, A Galindo, ... Fetal diagnosis and therapy 43 (2), 81-89, 2018	133	2018
Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction I Herraiz, LA Dröge, E Gómez-Montes, W Henrich, A Galindo, S Verlohren Obstetrics & Gynecology 124 (2 PART 1), 265-273, 2014	124	2014
Potential Relevance of α₁-Adrenergic Receptor Autoantibodies in Refractory Hypertension K Wenzel, H Haase, G Wallukat, W Derer, S Bartel, V Homuth, F Herse, ... PloS one 3 (11), e3742, 2008	123	2008

Systemet kan ikke utføre handlingen. Prøv på nytt senere.

Artikler 1–20

Sitater per år

Duplikatsitater

Sammenslåtte sitater

Legg til medforfattereMedforfattere

Følg

Sitert av

Medforfattere